Skip to main content
SpringerLink
Log in

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances

Proceedings of the Second International Conference on Malignant Lymphomas, Lugano, Switzerland, June 13 – 16, 1984

  • Conference proceedings
  • © 1985

Overview

Editors:
  1. Franco Cavalli

    1. Division of Oncology, Ospedale San Giovanni, Bellinzona, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. G. Bonadonna

    1. Istituto Nazionale, per lo Studio e la Cura dei Tumori, Milano, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Marcel Rozencweig

    1. Pharmaceutical Research & Development Division, Bristol-Myers Company, Syracuse, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Developments in Oncology (DION, volume 32)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 469.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 599.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 599.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (68 papers)

  1. Front Matter

    Pages I-XV
    Download chapter PDF

  2. Immunopathology

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. The cell of origin of Hodgkin’s disease

      • C. W. Berard
      Pages 3-6

    3. Hodgkin’s disease: Further information derived from cell lines

      • H. Burrichter, M. Schaadt, C. Kortmann, W. Heit, E. Schell-Frederick, H. Stein et al.
      Pages 7-15

    4. Origin and biologic function of Reed-Sternberg cells

      • R. I. Fisher, S. E. Bates, D. J. Volkman, V. Diehl, T. T. Hecht, D. L. Longo
      Pages 17-24

    5. Immunologic phenotypes of non-Hodgkin’s lymphomas: Correlation with morphology and function

      • E. S. Jaffe, O. J. Cossman, L. M. Neckers, R. M. Braziel, C. R. Simrell
      Pages 25-36

    6. Non-Hodgkin’s lymphoma with multilobated nuclei is not a distinct pathologic entity

      • Ph. M. Kluin, S. C. J. Van Der Putte, H. J. Schuurman, L. H. P. M. Rademakers, S. Poppema, J. A. M. Van Unnik
      Pages 37-44

    7. Burkitt’s lymphoma: Multiparametric analysis of 55 cell lines with special reference to morphometry

      • P. Felman, P. A. Bryon, O. Gentilhomme, J. P. Magaud, A. M. Manel, B. Coiffier et al.
      Pages 45-55

    8. Regulation of T-cell colony formation in the absence of added growth factors, in patients with T-cell malignancies

      • V. Georgoulias, M. Allouche, C. Jasmin
      Pages 57-69

  3. Cytogenetics

    1. Front Matter

      Pages 71-71
      Download chapter PDF

    2. Banded chromosome abnormalities in non-Hodgkin’s lymphoma. Correlations with morphology, immunologic phenotype and clinical course

      • C. D. Bloomfield, D. C. Arthur, E. G. Levine, G. Frizzera, K. J. Gajl-Peczalska, T. W. Lebien et al.
      Pages 73-80

    3. Chromosomal aberrations in leukemic low-grade malignant B-cell lymphoproliferative neoplasias

      • G. Gahrton, G. Juliusson, K. H. Robert, K. Friberg, L. Zech
      Pages 81-87

    4. Chromosome abnormalities in Burkitt lymphoma and Burkitt-type acute lymphoblastic leukemia

      • A. De La Chapelle
      Pages 89-99

    5. DNA content and proliferation in non-Hodgkin’s lymphoma: Flow cytofluorometric DNA analysis in relation to the Kiel classification

      • B. Christensson, B. Tribukait, P. Biberfeld
      Pages 101-114

    6. Oncogenes in human neoplasms

      • G. M. Cooper
      Pages 115-122

    7. Stage specific transforming genes in lymphoid neoplasms

      • M. A. Lane, H. A. F. Stephens, M. B. Tobin, K. Doherty
      Pages 123-127

  4. Biochemical markers

    1. Front Matter

      Pages 129-129
      Download chapter PDF

    2. DNA synthetic and degradative pathways in malignant lymphomas

      • A. V. Hoffbrand, A. D. Ho
      Pages 131-139

    3. Enzymes involved in adenosine metabolism in normal or leukemic lymphocytes

      • J. C. Mani, J. C. Bonnafous, G. Clofent, J. Favero, A. Gartner, J. Dornand
      Pages 141-149

    4. Purine metabolism in normal and pathologic lymphoid cell differentiation

      • H. J. Schuurman, J. P. R. M. Van Laarhoven, G. C. De Gast
      Pages 151-161
Back to top

Keywords

About this book

Malignant lymphomas remain a fascinating research topic for clinicians as well as basic scientists. Rapidly increasing technical sophistication, ex­ panded knowledge and broader implications of new findings underline the need for a forum to integrate the latest developments in the multiple areas involved in the challenging study of lymphoid malignancies. This volume includes contributions of renowned experts and is based on a selection of papers presented at the Second International Conference on Malignant Lymphomas that was held in Lugano, Switzerland, in June 1984. Updated information is provided on various experimental fields including cell biolo­ gy, immunology, genetics and cell biochemistry. Particular attention has been given to special clinical entities such as the lymphomas associated with the Acquired Immune Deficiency Syndrome. Recent advances in the treat­ of Hodgkin's disease, ncin-Hodgkin's lymphomas and childhood lym­ ment phomas are highlighted with emphasis on growing experience with new therapeutic approaches including monoclonal antibodies and bone marrow transplantation. The contents of the volume reflect and translate numerous avenues of exploration. While there might be some unavoidable overlap, most appear essentially complementary. The intent of the Program Committee of the Second International Conference on Malignant Lymphomas was to promote further interactions between all those who are devoting major efforts to elucidate the nature of these diseases or their optimal therapy. This volume will hopefully amplify this objective. The Editors wish to thank the contributors for delivering the manuscripts on schedule.

Editors and Affiliations

  • Division of Oncology, Ospedale San Giovanni, Bellinzona, Switzerland

    Franco Cavalli

  • Istituto Nazionale, per lo Studio e la Cura dei Tumori, Milano, Italy

    G. Bonadonna

  • Pharmaceutical Research & Development Division, Bristol-Myers Company, Syracuse, USA

    Marcel Rozencweig

Bibliographic Information

  • Book Title: Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances

  • Book Subtitle: Proceedings of the Second International Conference on Malignant Lymphomas, Lugano, Switzerland, June 13 – 16, 1984

  • Editors: Franco Cavalli, G. Bonadonna, Marcel Rozencweig

  • Series Title: Developments in Oncology

  • DOI: https://doi.org/10.1007/978-1-4613-2607-6

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Martinus Nijhoff Publishers, Boston 1985

  • Hardcover ISBN: 978-0-89838-727-8Published: 31 January 1986

  • Softcover ISBN: 978-1-4612-9632-4Published: 05 October 2011

  • eBook ISBN: 978-1-4613-2607-6Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XVI, 669

  • Topics: Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation